March 14, 2024

Change Healthcare this week provided an anticipated timeline for resolution of a late February cyberattack on its healthcare payment and revenue cycle management operations. The company anticipated electronic payment functionality to be restored by March 15 with claims network and software connectivity testing to begin March 18.

Change Healthcare executives continue to work collaboratively with the U.S. Department of Health and Human Services (HHS) to support healthcare providers impacted by the cyberattack to ensure that patient care is minimally disrupted. The Centers for Medicare and Medicaid Services (CMS) also announced an application process for providers to receive advance payments for Medicare Part B services in addition to Part A. Medicare Administrative Contractors have instructions available for requesting accelerated advance payments on their websites. CMS is also encouraging Medicaid and Medicare Advantage providers to make prospective payments available to impacted providers and to suspend prior authorization requirements.

UnitedHealth Group is maintaining a website to update impacted providers on its response to the attack.

For questions or to report specific issues your practices are facing as a result of the Change Healthcare cyberattack, contact Katie Keysor, American College of Radiology® Senior Director of Economic Policy.


Related ACR News

  • State Legislatures Are Active As May Begins

    The American College of Radiology® (ACR®) is providing this weekly update on state bills as many state legislatures look to the end of their legislative sessions in the month of May.

    Read more
  • ACR Attends April 2025 RUC Meeting

    The ACR® participated in the American Medical Association/Specialty Society RVS Update Committee (RUC) meeting where they heard an update on the AMA’s Physician Practice Information Survey.

    Read more
  • Senate Committee Hearing Covers Concerns Related to Biomedical Research

    The U.S. Senate Committee held a hearing to discuss the importance of U.S. biomedical research for the nation’s health and economy.

    Read more